Home 
Today's Top Picks 
Top Performers 
Watchlist 
My Robo Portfolios 
ETF Zone 
Help & Tutorial 
Cancel anytime
- Chart
- Upturn Summary
- Highlights
- Revenue
- Valuation
Upturn AI SWOT - About
Doximity Inc (DOCS)
Today’s top pick
- BUY Advisory
- SELL Advisory (Profit)
- SELL Advisory (Loss)
- Profit
- Loss
- Pass (Skip investing)
Stock price based on last close (see disclosures)
- ALL
- YEAR
- MONTH
- WEEK
Upturn Advisory Summary
07/03/2025: DOCS (4-star) is a STRONG-BUY. BUY since 6 days. Profits (2.12%). Updated daily EoD!
Upturn Star Rating
Above Average Performance
These Stocks/ETFs, based on Upturn Advisory, frequently surpass the market, reflecting reliable and trustworthy advice.
Number of Analysts
19 Analysts rated it
Moderately tracked stock, growing coverage, gaining market and investor attention.
1 Year Target Price $61.33
1 Year Target Price $61.33
| 5 | Strong Buy |
| 3 | Buy |
| 11 | Hold |
| 0 | Sell |
| 0 | Strong Sell |
Analysis of Past Performance
Type Stock | Historic Profit -0.7% | Avg. Invested days 32 | Today’s Advisory Strong Buy |
Upturn Star Rating | Upturn Advisory Performance  3.0 | Stock Returns Performance  1.0 |
| Profits based on simulation | Last Close 07/03/2025 |
Key Highlights
Company Size Large-Cap Stock | Market Capitalization 11.59B USD | Price to earnings Ratio 55.58 | 1Y Target Price 61.33 |
Price to earnings Ratio 55.58 | 1Y Target Price 61.33 | ||
Volume (30-day avg) 19 | Beta 1.32 | 52 Weeks Range 25.00 - 85.21 | Updated Date 07/5/2025 |
52 Weeks Range 25.00 - 85.21 | Updated Date 07/5/2025 | ||
Dividends yield (FY) - | Basic EPS (TTM) 1.11 |
Analyzing Revenue: Products, Geography and Growth
Revenue by Products
Product revenue - Year on Year
Earnings Date
Report Date - | When - | Estimate - | Actual - |
Profitability
Profit Margin 39.13% | Operating Margin (TTM) 35.32% |
Management Effectiveness
Return on Assets (TTM) 12.31% | Return on Equity (TTM) 22.5% |
Valuation
Trailing PE 55.58 | Forward PE 44.64 | Enterprise Value 10683727377 | Price to Sales(TTM) 20.31 |
Enterprise Value 10683727377 | Price to Sales(TTM) 20.31 | ||
Enterprise Value to Revenue 18.73 | Enterprise Value to EBITDA 44.37 | Shares Outstanding 136907008 | Shares Floating 133658969 |
Shares Outstanding 136907008 | Shares Floating 133658969 | ||
Percent Insiders 2.24 | Percent Institutions 93.7 |
Upturn AI SWOT
Doximity Inc
Company Overview
History and Background
Doximity was founded in 2010 with the mission of helping physicians be more connected and productive. It launched its platform in 2011. The company aimed to create a professional network specifically for healthcare professionals, initially focusing on helping doctors connect and communicate securely. Over time, Doximity expanded its services to include tools for career development, continuing medical education (CME), telehealth, and pharmaceutical marketing.
Core Business Areas
- Marketing Solutions: Doximity provides advertising and marketing solutions to pharmaceutical companies and healthcare organizations, allowing them to reach and engage with physicians directly on the platform.
- Recruiting Solutions: Doximity offers tools and services to help healthcare organizations recruit physicians and other healthcare professionals, leveraging its network and data insights.
- Subscription: Doximity provides various paid subscription services to physicians, hospitals, and pharmaceutical companies providing access to expanded and tailored networks, data and capabilities.
Leadership and Structure
Doximity is led by CEO Jeff Tangney. The company has a structured leadership team encompassing various departments, including marketing, sales, engineering, and product development.
Top Products and Market Share
Key Offerings
- Doximity Network: The core platform and professional network for healthcare professionals, facilitating communication, collaboration, and knowledge sharing. It has a very large market share among physicians in the US. Competitors include LinkedIn and smaller medical professional networks. Doximity claims that over 80% of U.S. physicians are members.
- Dialer: A telehealth solution enabling physicians to connect with patients via secure video calls. Doximity provides a free version to its base users. Competitors include Teladoc Health (TDOC) and Amwell (AMWL).
- Recruiting Solutions: Doximity Talent Finder. Allows healthcare recruiters to find and contact physicians. Competitors include LinkedIn Recruiter and specialized healthcare recruiting firms.
- Marketing Solutions: Brand advertising and other marketing programs for pharmaceutical companies. Competitors include traditional advertising channels and other digital health advertising platforms.
Market Dynamics
Industry Overview
The healthcare technology industry is experiencing significant growth, driven by the increasing adoption of digital health solutions, the need for improved communication and collaboration among healthcare professionals, and the growing demand for telehealth services. The industry is highly competitive, with both established players and emerging startups vying for market share.
Positioning
Doximity is a leading platform for healthcare professionals, particularly physicians, in the United States. Its competitive advantages include its large user base, its focus on providing solutions tailored to the needs of healthcare professionals, and its strong brand recognition.
Total Addressable Market (TAM)
The TAM for Doximity is estimated to be in the billions of dollars, encompassing the market for healthcare professional networking, telehealth, recruiting, and marketing. Doximity is well-positioned to capture a significant share of this market due to its established platform and strong relationships with healthcare professionals and organizations.
Upturn SWOT Analysis
Strengths
- Large and engaged user base of healthcare professionals
- Strong brand recognition and reputation
- Focus on providing solutions tailored to the needs of healthcare professionals
- Recurring revenue model
- High profit margins
Weaknesses
- Reliance on the US market
- Potential saturation of the physician market
- Limited presence in other healthcare sectors beyond physicians
- Privacy Concerns
Opportunities
- Expansion into international markets
- Development of new products and services, such as AI-powered clinical decision support
- Strategic acquisitions to expand its platform and reach
- Increased adoption of telehealth
Threats
- Increased competition from established players and emerging startups
- Changes in healthcare regulations and reimbursement policies
- Data breaches and privacy concerns
- Economic downturn affecting advertising and marketing budgets
Competitors and Market Share
Key Competitors
- MDRX
- ADUS
- TDOC
- AMWL
Competitive Landscape
Doximity's advantages over competitors include its large and engaged user base of healthcare professionals, its focus on providing solutions tailored to the needs of healthcare professionals, and its strong brand recognition. Disadvantages include its reliance on the US market and the potential saturation of the physician market.
Major Acquisitions
THMED
- Year: 2021
- Acquisition Price (USD millions): 70
- Strategic Rationale: The acquisition of THMED bolsters Doximity's telehealth capabilities, integrating a robust virtual care platform for physicians and patients.
Growth Trajectory and Initiatives
Historical Growth: Doximity has experienced strong growth in recent years, driven by the increasing adoption of its platform and the demand for its solutions. Growth has been supported by increases in user engagement.
Future Projections: Future growth projections depend on market conditions and analyst estimates which require a continuous feed. However, growth is expected to continue, driven by secular trends.
Recent Initiatives: Recent initiatives include partnerships with healthcare organizations, the launch of new products and services, and expansion into new markets.
Summary
Doximity is a strong player in the healthcare professional networking and telehealth space, fueled by its large user base and targeted offerings. Its high profit margins and recurring revenue models support its stability. However, overreliance on the US market and potential market saturation pose risks. Expansion into new products and markets is crucial for continued growth.
Peer Comparison
Sources and Disclaimers
Data Sources:
- Company Filings
- Industry Reports
- Analyst Estimates
- Doximity Investor Relations
Disclaimers:
The data and analysis provided are for informational purposes only and should not be considered financial advice. Market conditions can change, and you should consult a financial advisor before making any investment decisions.
AI Summarization is directionally correct and might not be accurate.
Summarized information shown could be a few years old and not current.
Fundamental Rating based on AI could be based on old data.
AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.
About Doximity Inc
Exchange NYSE | Headquaters San Francisco, CA, United States | ||
IPO Launch date 2021-06-24 | Co-Founder, CEO & Chairperson Mr. Jeffrey A. Tangney | ||
Sector Healthcare | Industry Health Information Services | Full time employees 830 | Website https://www.doximity.com |
Full time employees 830 | Website https://www.doximity.com | ||
Doximity, Inc. operates as a digital platform for medical professionals in the United States. Its platform provides its members with digital tools built for medicine, that enables its members to collaborate with colleagues, stay up to date with the latest medical news and research, manage their careers and on-call schedules, streamline documentation and administrative paperwork, and conduct virtual patient visits. The company primarily serves physicians, nurse practitioners, physician assistants, medical students, pharmaceutical manufacturers, and healthcare systems. The company was formerly known as 3MD Communications, Inc. and changed its name to Doximity, Inc. in June 2010. Doximity, Inc. was incorporated in 2010 and is headquartered in San Francisco, California.
Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.